This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Aug;3(8):426-7.

doi: 10.1038/ncpneph0540. Epub 2007 Jun 19.

Minimizing ciclosporin in renal transplant recipients on daclizumab, mycophenolate and steroids

Suphamai Bunnapradist¹, Gabriel M Danovitch

Affiliations

Affiliation

¹ David Geffen School of Medicine, Department of Medicine, Division of Nephrology, Kidney and Pancreas Transplant Research Office, Los Angeles, CA 90095-7306, USA. bunnapradist@mednet.ucla.edu

PMID: 17579596
DOI: 10.1038/ncpneph0540

Comment

Minimizing ciclosporin in renal transplant recipients on daclizumab, mycophenolate and steroids

Suphamai Bunnapradist et al. Nat Clin Pract Nephrol. 2007 Aug.

. 2007 Aug;3(8):426-7.

doi: 10.1038/ncpneph0540. Epub 2007 Jun 19.

Authors

Suphamai Bunnapradist¹, Gabriel M Danovitch

Affiliation

¹ David Geffen School of Medicine, Department of Medicine, Division of Nephrology, Kidney and Pancreas Transplant Research Office, Los Angeles, CA 90095-7306, USA. bunnapradist@mednet.ucla.edu

PMID: 17579596
DOI: 10.1038/ncpneph0540

No abstract available

PubMed Disclaimer

Comment on

Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study.
Ekberg H, Grinyó J, Nashan B, Vanrenterghem Y, Vincenti F, Voulgari A, Truman M, Nasmyth-Miller C, Rashford M. Ekberg H, et al. Am J Transplant. 2007 Mar;7(3):560-70. doi: 10.1111/j.1600-6143.2006.01645.x. Epub 2007 Jan 22. Am J Transplant. 2007. PMID: 17229079 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.